Clinical Trial Update: Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating uPAR-PET/CT for prognostication in head and neck cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED